ArticleScientific reports2025
Intratesticular copper oxide nanoparticles induce dose-dependent chemical castration in male mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Paternal Chronic Exposure to Copper Nanoparticles (CuNPs) Impairs Testicular Androgen and Estrogen Signalling in Adult Male Offspring in Mice.Biological trace element research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical castration represents a non-surgical alternative to achieve male sterility by inducing azoospermia, with growing interest in nanoparticle-based agents owing to their targeted toxicity. This study aimed to determine whether intratesticular administration of copper oxide nanoparticles (CuO NPs) is effective in the chemical castration of male mice, and whether biochemical and histological changes can be assessed. Fifty-six adult male mice were divided into seven groups (n = 8 per group): a surgically castrated cohort, a control group, a sham group, and four experimental groups receiving CuO NPs at concentrations of 5, 10, 20, and 40 mg/mL. The assessment included fertility analysis after 30 days of treatment, sperm quality, testicular tissue, histological parameters, oxidative status, and gene expression. Testis weight, sperm parameters, and testosterone levels were significantly reduced by exposure to CuO NPs, but oxidative stress and DNA damage increased in a dose-dependent manner. Higher doses also decreased the expression of anti-apoptotic genes (Bcl-2) and increased that of pro-apoptotic genes (Bax and caspase-3). The correlation between these alterations and lower fertility indices highlighted the reproductive toxicity of CuO NPs. There were no noticeable differences between the control and sham groups for comparison. These findings suggest that intratesticular CuO NPs have potential as a method for chemical castration, offering a less invasive and more economical option for population-control applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.